APLN: A Promising Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
Journal of Molecular Cell Biology · 22.07.2026
DOI: 10.1093/jmcb/mjag018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 22.07.2026. Verfasst von Jiwu Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Jiwu Guo, Wenzhang Wu, Yujing Qi, Lingyun Guo, Jie Mao, Yumin Li; APLN: A Promising Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma, Journa
Autor:innen und Institutionen
- Department of General Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
- Gansu Province Key Laboratory of Environmental Oncology, Lanzhou 730030, China.
Zitieren
APA
Guo, J., Wu, W., Qi, Y., Guo, L., Mao, J., & Li, Y. (2026). APLN: A Promising Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjag018
Vancouver
Guo J, Wu W, Qi Y, Guo L, Mao J, Li Y. APLN: A Promising Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. Journal of Molecular Cell Biology. 2026. doi:10.1093/jmcb/mjag018
BibTeX
@article{Guo2026,
author = {Guo, Jiwu and Wu, Wenzhang and Qi, Yujing and Guo, Lingyun and Mao, Jie and Li, Yumin},
title = {APLN: A Promising Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma},
journal = {Journal of Molecular Cell Biology},
year = {2026},
doi = {10.1093/jmcb/mjag018}
}
EUVIMED